Acrx shareholder alert: bronstein, gewirtz & grossman, llc notifies acelrx pharmaceuticals, inc. investors of class action and encourages investors to contact the firm

New york, june 10, 2021 /prnewswire/ -- attorney advertising -- bronstein, gewirtz & grossman, llc notifies investors that a class action lawsuit has been filed against acelrx pharmaceuticals, inc. ("acelrx" or "the company") (nasdaq: acrx) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired acelrx securities between march 17, 2020 and february 12, 2021, (the "class period"). such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/acrx.
ACRX Ratings Summary
ACRX Quant Ranking